Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular
those with haematological malignancies undergoing remission-induction chemotherapy for …

Despite advances in preventive, diagnostic, and therapeutic interventions, invasive fungal
infections cause significant morbidity and mortality in immunocompromised patients. The …

To determine the epidemiology and trends of invasive fungal infections (IFIs) in France, we
analyzed incidence, risk factors, and in-hospital death rates related to the most frequent IFIs …

Invasive fungal infections are increasing in incidence and are associated with substantial
mortality. Improved diagnostics and the availability of new antifungals have revolutionized …

Most antifungal peptides (AFPs), if not all, have membrane activity, while some also have
alternative targets. Fungal membranes share many characteristics with mammalian …

Despite advancements in the treatment and supportive care of patients with malignant
disorders, neutropenia remains the major side effect of most antineoplastic regimens …

The increasing incidence of drug-resistant pathogens and host toxicity of existing antifungals
attracts attention toward the efficacy of natural products as antifungals in mucocutaneous …

Background Controversy still surrounds the question whether yeasts found in the gut are
causally related to disease, constitute a health hazard, or require treatment. Methods The …

Anti-β-glucan antibodies elicited by a laminarin-conjugate vaccine confer cross-protection to
mice challenged with major fungal pathogens such as Candida albicans, Aspergillus …

OBJECTIVES: To review the current literature on mucormycosis in immunocompentent/
otherwise healthy individuals, to which five new cases with maxillary sinus involvement have …